SnET2 photodynamic therapy: Phase I and II Update

PDT Inc. (PDTI), Santa Barbara, Calif. Product: SnET2 photodynamic therapy Indication: Cutaneous breast cancer Status: PDTI expanded its Phase II/III trial to include a broader patient population. The...